×
0 0 0 0.0117145899893503 0.0117145899893503 0.0117145899893503 0.0777422790202343 0.136027689030884
Stock impact report

Magenta Therapeutics Presents Preclinical Data on Targeted Non-Genotoxic Conditioning Programs, Including First Conditioning Development Candidate

Magenta Therapeutics, Inc (MGTA)  More Company Research Source: Business Wire
Last magenta therapeutics, inc earnings: 8/8 08:00 am Check Earnings Report
PDF -- Data in non-human primates from C100 program show potent stem and immune cell depletion with anti-CD45 amanitin ADC that is well tolerated at efficacious doses -- -- C200 development candidate, anti-CD117 amanitin ADC, showed potent and selective stem cell depletion and immune system preservation in non-human primates and was well tolerated -- -- Additional poster highlights preclinical data on anti-leukemia survival benefit with C100 and C200 targeted conditioning programs -- CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Magenta Therapeutics (NASDAQ:MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today announced that the Company highlighted preclinical research on its targeted conditioning programs in four presentations and posters at the Transplant and Cellular Therapy (TCT) annual meeting. [Read more]
Impact snapshot Event time: MGTA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
MGTA alerts
from News Quantified
Opt-in for
MGTA alerts

from News Quantified
Opt-in for
MGTA alerts

from News Quantified